TABRECTA 150 mg/1 (Capmatinib TABLET, FILM COATED) 150 mg/1

TABRECTA 150 mg is a film-coated tablet used for targeted therapy. It contains capmatinib, a medication prescribed for specific conditions. Learn more about its uses and effects.

Strength

150 mg/1

Pack Size

56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-94)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TABRECTA 150 mg is primarily used in targeted therapy for certain types of cancer. It works by inhibiting specific proteins that contribute to cancer cell growth. Patients often wonder, 'What is TABRECTA used for?' This medication is designed to interfere with the growth and spread of cancer cells.

Side Effects

Common effects of TABRECTA 150 mg may include nausea, vomiting, and fatigue. Some users also report diarrhea and swelling in the limbs. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

TABRECTA 150 mg should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Patients should avoid breaking or crushing the tablets unless directed. Always store the medication in a cool, dry place away from children and pets.

Avoid Interactions

TABRECTA 150 mg may interact with certain medications, including those that affect liver enzymes. It is crucial to inform your healthcare provider about all medications you are taking. Alcohol and other substances may also interact with TABRECTA, so it's important to discuss any potential interactions with a healthcare professional.

Frequently Asked Questions

TABRECTA is used in targeted therapy for specific types of cancer. It works by inhibiting proteins that contribute to cancer cell growth.

TABRECTA should be taken orally, usually with or without food. Follow your healthcare provider's instructions for the best results.

Common side effects may include nausea, vomiting, fatigue, diarrhea, and swelling in the limbs. Always consult your healthcare provider if you experience any adverse effects.

Unless directed by your healthcare provider, avoid breaking or crushing TABRECTA tablets. Follow the administration instructions provided.

If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue with your regular schedule.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.